Skip to main content
OpenTrials
Completed

NCT Number: NCT05188482

Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19

This article describes a case of successful treatment of a 59-year-old man with sepsis as a result of periprosthetic infection against the background of severe SARS-CoV-2-19, who was hospitalized for 59 days, 57 of which were in the intensive care unit. Vibroacoustic pulmonary therapy, the concept of noninvasive ventilation, syndrome therapy, combination antibiotic therapy taking into account the pathogen and antibiotic sensitivity were used in the treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

SARS CoV 2 Infection COVID-19 Coinfection Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

59 year–59 year

Sex eligibility

Male

Study type

Observational

Primary location

NATIONAL CENTER Scientific Center of Traumatology and Orthopedics named after Academician Batpenov N.D.

Astana, 010000, Kazakhstan

About this study

During the pandemic caused by SARS-CoV-2-19, the whole world faced difficulties. Nevertheless, surgeons had to perform surgical treatment for patients who needed immediate help with a confirmed coronavirus infection [1, 2, 3].

Periprosthetic joint infection is a severe and undesirable consequence after arthroplasty [4, 5]. Patients with coronavirus infection and bacterial infection correlate with an unfavorable outcome [6, 7, 8] The effect of vibroacoustic therapy in the treatment of various conditions has not been sufficiently studied [9, 10]. This clinical case describes the complex therapy of a patient with a periprosthetic infection on the background of SARS-CoV-2 using a vibroacoustic pulmonary device.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • P/F less 300 torr
  • COVID-19 Virus Infection

Exclusion criteria

  • children
  • acute stroke
  • acute coronary syndrome
  • DVT
  • implanted pacemaker
  • rib fracture
  • infection on chest

Treatment and study plan

vibroacoustic therapy

Device

Vibroacoustic respiratory therapy

Primary outcomes

  1. Change of time spent on ventilation

    Time frame: 1-2 days

    Changing of the time spent by patients on mechanical ventilation

Sponsors and collaborators

Lead sponsor

Astana Medical University

Other

Registry information

Official study title

Complex Treatment Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19: Case Report.

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
Jan 12, 2022
Registry last updated
Jan 12, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.